Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering
ÌÇÐÄ´«Ã½
CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering Majzner, R. G., Frank, M. J., Mount, C., Tousley, A., Kurtz, D. M., Sworder, B., Murphy, K. A., Manousopoulou, A., Kohler, K., Rotiroti, M., Spiegel, J. Y., Natkunam, Y., Younes, S. F., Sotillo, E., Vandon Duong, Macaulay, C., Good, Z., Xu, P., Labanieh, L., Wang, L. D., Alizadeh, A. A., Monje, M., Miklos, D. B., Mackall, C. L. AMER SOC HEMATOLOGY. 2020View details for
View details for